当前位置: 首页 > 期刊 > 《医学信息》 > 2018年第22期
编号:13339419
PiC基因与人体疾病机制研究(4)
http://www.100md.com 2018年6月4日 《医学信息》 2018年第22期
     [21]Chen Q,Xu H,Xu A,et al.Inhibition of Bcl-2 sensitizesmitochondrial permeability transition pore (MPTP) openingin ischemia-damaged mitochondria[J].PLoS ONE,2015,10(3):e0118834.

    [22]Galluzzi L,Blomgren K,Kroemer G.Mitochondrial membrane permeabilization in neuronal injury[J].Nat Rev Neurosci,2009(10):481-494.

    [23]Haworth RA,Hunter DR.The Ca2+-induced membrane transition in mitochondria.Ⅱ.Nature of the Ca2+ trigger site[J].Arch Biochem Biophys,1979,195(2):460-467.

    [24]Jonas EA,Porter GA,Alavian KN.Bcl-xl in neuroprotection and plasticity[J].Frontiers in physiology,2014(5):355.

    [25]Baines CP,Molkentin JD.Adenine nucleotide translocase-1 induces cardiomyocyte death through upregulation of the pro-apoptotic protein Bax[J].J Mol Cell Cardiol,2009,46(6):969-977.

    [26]Perciavalle RM,Stewart DP,Koss B,et al.Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration[J].Nature cell biology,2012(14):575-583.

    收稿日期:2018-9-5;修回日期:2018-9-25

    編辑/雷华, 百拇医药(郭金莲 徐炜棉 卢均坤)
上一页1 2 3 4